May 26th – May 28th: Defymed is happy to announce its participation to annual congress of ISCT (International Society For Cell & Gene Therapy), which will take place from May 26th to 28th 2021.
Established since 1992, this well-recognized international event will provide an extensive update on latest developments of cell and gene therapy for an increasing number of disease. A wide range of subjects will be treated by academic scientists, physician, industry project manager and regulatory affairs experts to ensure a multidisciplinary approach. Even if this edition is virtual, It is a great opportunity for Defymed to find new partners to accelerate development of MailPan® device applications which includes type 1 diabetes and Hemophilia A.
The mains topics of #ISCT2021 congress include exosomes, immuno- and gene therapies, stem cells engineering, tissue engineering and regenerative medicine or all aspects related to commercialization. This rich and translational scientific program will constitute a valuable update on innovative therapies.
Jordan MAGISSON our R&D Manager will follow the conferences online